(Q40759660)

23 September 2017

Functional characterization of WT1 binding sites within the human vitamin D receptor gene promoter (English)

1 reference

23 September 2017

0 references

Lee TH

1

1 reference

PubMed ID

11773605

23 September 2017

Pelletier J

series ordinal

2

1 reference

PubMed ID

11773605

23 September 2017

language of work or name

1 reference

21 December 2001

1 reference

23 September 2017

Physiological Genomics

1 reference

23 September 2017

7

1 reference

23 September 2017

187-200

1 reference

23 September 2017

2

1 reference

Identification of nuclear localization signals within the zinc fingers of the WT1 tumor suppressor gene product

23 September 2017

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

Homozygous somatic Wt1 point mutations in sporadic unilateral Wilms tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

Ciao 1 is a novel WD40 protein that interacts with the tumor suppressor protein WT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

The Wilms' tumor suppressor gene (wt1) product regulates Dax-1 gene expression during gonadal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

WT-1 is required for early kidney development

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

Molecular basis for modulation of biological function by alternate splicing of the Wilms' tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

Wilms tumor and the WT1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

Zinc finger point mutations within the WT1 gene in Wilms tumor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

Transcriptional repression mediated by the WT1 Wilms tumor gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 requires association with the inducible chaperone Hsp70

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

Physical and functional interaction between WT1 and p53 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

The Wilms' tumor gene product (WT1) modulates the response to 1,25-dihydroxyvitamin D3 by induction of the vitamin D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

ASSOCIATION OF WILMS'S TUMOR WITH ANIRIDIA, HEMIHYPERTROPHY AND OTHER CONGENITAL MALFORMATIONS

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

Antagonism of WT1 activity by protein self-association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

The WT1 Wilms' tumor suppressor gene: how much do we really know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

WT1-mediated transcriptional activation is inhibited by dominant negative mutant proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

Reversible inhibition of mammary gland growth by transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

Identification of connective tissue growth factor as a target of WT1 transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

Fine structure analysis of the WT1 gene in sporadic Wilms tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

A second transcriptionally active DNA-binding site for the Wilms tumor gene product, WT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOLGENOMICS.00046.2001

10.1152/PHYSIOLGENOMICS.00046.2001

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference

PubMed ID

11773605